Statistik Asas
| CIK | 1779372 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to HeartBeam, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 13, 2025 |
Table of content UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEAR |
|
| July 16, 2025 |
Third Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan Exhibit 10.1 THIRD AMENDMENT TO THE HEARTBEAM, INC. 2022 EQUITY INCENTIVE PLAN Effective as of July 11, 2025, HeartBeam, Inc., a Delaware corporation (the “Company”), established, and the shareholders approved, the third amendment (the “Third Amendment”) to the Company’s 2022 Equity Incentive Plan (the “2022 Equity Plan”). By adoption of this instrument, the Company now desires to amend the 2022 E |
|
| July 16, 2025 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2025 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Number) (IRS E |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State |
|
| May 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| May 13, 2025 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HE |
|
| May 5, 2025 |
Exhibit 99.1 HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth Board expansion reflects Company’s commitment to leadership and innovation in remote cardiac monitoring SANTA CLARA, CA — May 5, 2025 — HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2025 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 25, 2025 |
Letter from Marcum LLP to the Securities and Exchange Commission Exhibit 16.1 April 25, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: HeartBeam, Inc. Commission File Number 001-41060 Commissioners: We have read the statements made by HeartBeam, Inc. under Item 4.01 of its Form 8-K dated April 21, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2025 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period over from to Commission File Number: 001-41060 HEARTBEAM, INC. (Exa |
|
| February 26, 2025 |
Exhibit 99.1 HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock ● Additional gross proceeds of approximately $1.5 Million ● Follows successful closing of $10 million underwritten offering ● Funding is part of the Company’s strategic plan focusing on key growth milestones and preparation for U.S. commercialization SANTA CLARA, CA – Fe |
|
| February 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2025 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| February 18, 2025 |
Exhibit 99.1 February 13, 2025 HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock ● HeartBeam system was recently cleared by the U.S. Food and Drug Administration (FDA) for comprehensive arrhythmia assessment ● 510(k) application submitted to the FDA for the Company’s groundbreaking 12-lead electrocardiogram (ECG) synthesis software ● Funding is part of the C |
|
| February 18, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| February 18, 2025 |
Exhibit 1.1 5,882,353 SHARES of Common Stock HEARTBEAM, INC. UNDERWRITING AGREEMENT February 12, 2025 Public Ventures, LLC (d/b/a MDB Capital) 14135 Midway Road, Suite G-150 Addison, TX 75001 Ladies and Gentlemen: The undersigned, HeartBeam, Inc., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Public Ventures, LLC d/b/a MDB |
|
| February 18, 2025 |
Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLI |
|
| February 14, 2025 |
HEARTBEAM, INC. Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-269520 Prospectus Supplement (to Prospectus dated February 10, 2023) HEARTBEAM, INC. 5,882,353 Shares of Common Stock We are offering 5,882,353 shares of our common stock, par value $0.0001, (the “Common Stock”) at an offering price of $1.70 pursuant to this prospectus supplement and the accompanying base prospectus. This offering is being unde |
|
| January 8, 2025 |
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus Dated January 8, 2025 Relating to Preliminary Prospectus dated December 23, 2024 Registration Statement No. |
|
| December 23, 2024 |
Subject to Completion, dated December [ ], 2024 Filed Pursuant to Rule 424(b)(5) Registration No. 333-269520 The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is declared effective. This prospectus is not an offer to sell the securities and it is not soliciting an offer to buy these securities in any jurisdict |
|
| November 7, 2024 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4106 |
|
| October 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 23, 2024 |
HeartBeam Branislav Vajdic Employment Agreement HEARTBEAM, INC. October 17, 2024 Branislav Vajdic [Address] Dear Branislav, This employment agreement amendment (the “Agreement”) amends your employment agreement executed September 19, 2021 (the “Original Employment Agreement”). All capitalized terms used herein that are not defined herein shall have the definitions set forth in the Original Employment Agreement. We are pleased to offer you the p |
|
| October 23, 2024 |
HeartBeam Rob Eno Employment Agreement HEARTBEAM, INC. October 14, 2024 Robert P. Eno [Address] Dear Rob, This employment agreement amendment (the “Agreement”) amends your employment agreement executed January 18, 2023 (the “Original Employment Agreement”). All capitalized terms used herein that are not defined herein shall have the definitions set forth in the Original Employment Agreement. We are pleased to offer you the position of |
|
| October 23, 2024 |
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization Exhibit 99.1 HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization •Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth •Founder and current CEO Branislav Vajdic named President to focus on advancing the Company’s groundbreaking vector-based technology for heart health, includin |
|
| September 10, 2024 |
Employment Agreement with Timothy Cruickshank, dated August 2 HEARTBEAM, INC. August 22, 2024 Timothy Cruickshank [Address] Dear Timothy: I am pleased to offer you a position with HeartBeam, Inc. (the “Company”), as Chief Financial Officer. If you decide to join us, you will receive an annual salary of $385,000, commencing on September 9, 2024. The salary will be paid semi-monthly in accordance with the Company’s normal payroll procedures. This salary will b |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2024 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| September 10, 2024 |
Exhibit 99.1 HeartBeam Names Timothy Cruickshank as Chief Financial Officer Seasoned MedTech Leader with Proven Track Record of Strategic Planning, Financial Stewardship and Commercial Success SANTA CLARA, CA – September 10, 2024 - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announ |
|
| August 14, 2024 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEA |
|
| June 18, 2024 |
Second Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan Exhibit 10.1 APPENDIX A SECOND AMENDMENT TO THE HEARTBEAM, INC. 2022 EQUITY INCENTIVE PLAN Effective as of June 12, 2024, HeartBeam, Inc., a Delaware corporation (the “Company”), established, and the shareholders approved, the Company’s 2022 Equity Incentive Plan (the “2022 Equity Plan”). By adoption of this instrument, the Company now desires to amend (the “Second Amendment”) the First Amendment |
|
| June 18, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Number) (IRS E |
|
| May 9, 2024 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HE |
|
| May 3, 2024 |
Prospectus Supplement Filed Pursuant to Rule 424(b)(5) (to Prospectus dated February 10, 2023) Registration No. |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 2, 2024 |
Sales Agreement by and between HeartBeam, Inc. and Public Ventures, LLC, dated May 2, 2024 $17,000,000 ATM Sales Agreement May 2, 2024 Public Ventures, LLC 14135 Midway Road Suite G-150 Addison, TX 75001 Ladies and Gentlemen: HeartBeam, Inc. |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☑ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| March 20, 2024 |
HeartBeam, Inc. Compensation Recovery Policy Exhibit 97.1 HeartBeam, Inc. Compensation Recovery Policy 1. Purpose. The purpose of this Compensation Recovery Policy of the Company (as amended from time to time, the “Policy”), dated as of November 30, 2023 to describe the circumstances in which current and former Executive Officers will be required to repay or return Erroneously Awarded Compensation to members of the Company Group. The Company |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEARTBEAM, INC. (Exact Na |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2024 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 14, 2023 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4106 |
|
| October 25, 2023 |
EX-99.1 Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the undersigned hereby agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto, the “Schedule 13D”) relating to the common stock, $0.000001 par value per share, of HeartBeam, |
|
| October 25, 2023 |
BEAT / HeartBeam Inc / STROME MARK E - SC 13D Activist Investment SC 13D 1 d554769dsc13d.htm SC 13D UNITED STATES SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* HEARTBEAM, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 42238H108 (CUSIP Number) Strome Group, LLC Attn: Mark E. Strome 13535 Ventura Boulevard, Suite C-525 Sherman Oaks, CA 91423 (310) 850-9700 (Name, |
|
| August 28, 2023 |
99.2 – Joint Filing Agreement, dated August 20, 2023, filed herewith. Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of Heartbeam, Inc., a Delaware corporation. This Joint F |
|
| August 28, 2023 |
BEAT / HeartBeam Inc / PUBLIC VENTURES, LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a) Heartbeam, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42238H108 (CUSIP Number) Andrew D. Hudders, Esq. Golenbock Eiseman Assor Bell & Peskoe LLP, 711 |
|
| August 10, 2023 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEA |
|
| July 26, 2023 |
Exhibit 99.1 HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors Renowned Vascular Physician and Researcher Brings Wealth of Clinical and Industry Experience to Board SANTA CLARA, CA – July 26, 2023 – HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today ann |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| July 13, 2023 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) HeartBeam, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.0001 p |
|
| July 13, 2023 |
As filed with the Securities and Exchange Commission on July 13, 2023 As filed with the Securities and Exchange Commission on July 13, 2023 Registration No. |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File N |
|
| July 11, 2023 |
First Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan Exhibit 10.1 FIRST AMENDMENT TO THE HEARTBEAM, INC. 2022 EQUITY INCENTIVE PLAN Effective as of June 15, 2022, HeartBeam, Inc., a Delaware corporation (the “Company”), established, and the shareholders approved, the Company’s 2022 Equity Incentive Plan (the “2022 Equity Plan”). By adoption of this instrument, the Company now desires to amend (the “First Amendment”) the 2022 Equity Plan to increase |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File N |
|
| June 8, 2023 |
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors Accomplished Medical Technology Leader and Veteran Investor Bring Strategic Experience and Vision to Board SANTA CLARA, CA – June 8, 2023 – HeartBeam, Inc. |
|
| June 2, 2023 |
BEAT / HeartBeam Inc / Schwartzberg Andrew - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. )* HeartBeam, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 42238H108 (CUSIP Number) May 2, 2023 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State |
|
| May 23, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ¨ Check the appropriate box: ☑ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| May 11, 2023 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HE |
|
| May 5, 2023 |
Form of Securities Purchase Agreement dated as of May 2, 2023 between HeartBeam, Inc. and Investor Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2023, between HeartBeam Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set forth i |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 4, 2023 |
HEARTBEAM, INC. 1,000,000 Shares of Common Stock Prospectus Supplement Filed Pursuant to Rule 424(b)(2) (to Prospectus dated February 10, 2023) Registration No. |
|
| May 3, 2023 |
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance HeartBeam to Focus on Becoming the Global Leader in Ambulatory Vectorcardiography, the Highest Resolution ECG Monitoring Platform Funding to Enable Company to Execute on Upcoming Clinical, Regulatory and Commercial Milestones, Extends Cash Runway into Late 2024 HeartBeam to Host Conference Call to Discuss Financing, Strategic Initiatives and First Quarter 2023 Financial Results on Thursday May 11, 2023 at 4:30 p. |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 21, 2023 |
HeartBeam, Inc. Shares of Common Stock Filed Pursuant to Rule 424(b)(2) Registration No. 333-269717 PROSPECTUS HeartBeam, Inc. 16,666,666 Shares of Common Stock We are offering up to 16,666,666 shares of common stock, par value .0001 (the “Common Stock”) of HeartBeam, Inc. (the “Company” or “HeartBeam”) at a public offering price of $1.50 per share. This is a “best efforts” offering. This offering will terminate on May 18, 2023 unless |
|
| April 17, 2023 |
As filed with the Securities and Exchange Commission on April 17, 2023. As filed with the Securities and Exchange Commission on April 17, 2023. Registration Statement No. 333-269717 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incorpo |
|
| April 17, 2023 |
Form of Placement Agent’s Warrant Exhibit 4.13 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPL |
|
| April 17, 2023 |
Form of Placement Agent Agreement Exhibit 1.1 PLACEMENT AGENCY AGREEMENT April [], 2023 Public Ventures, LLC 4209 Meadowdale Lane Dallas, Texas 95220 Attention: Investment Banking Ladies and Gentlemen: Introduction. Subject to the terms and conditions herein (this “Agreement”), HeartBeam, Inc., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of $25,000,000 of registered securities (the “Securities” |
|
| April 10, 2023 |
As filed with the Securities and Exchange Commission on April 10, 2023. As filed with the Securities and Exchange Commission on April 10, 2023. Registration Statement No. 333-269717 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incorpo |
|
| April 10, 2023 |
Form of Placement Agent Agreement Exhibit 1.1 PLACEMENT AGENCY AGREEMENT April [], 2023 Public Ventures, LLC 4209 Meadowdale Lane Dallas, Texas 95220 Attention: Investment Banking Ladies and Gentlemen: Introduction. Subject to the terms and conditions herein (this “Agreement”), HeartBeam, Inc., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of $25,000,000 of registered securities (the “Securities” |
|
| April 10, 2023 |
Form of Escrow Agreement for the offering Exhibit 10.17 Execution Copy SUBSCRIPTION ESCROW AGREEMENT This Subscription Escrow Agreement (the “Escrow Agreement”), dated as of the effective date (the “Effective Date”) set forth on Schedule 1 attached hereto (“Schedule 1”), by and among the corporation identified on Schedule 1 (the “Issuer”), Public Ventures, LLC, and Delaware Trust Company, as escrow agent hereunder (the “Escrow Agent”). WH |
|
| April 10, 2023 |
Form of Placement Agent’s Warrant Exhibit 4.13 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPL |
|
| April 10, 2023 |
Form of Subscription Agreement Exhibit 10.16 Subscription Agreement This subscription (this “Subscription”) is dated [●], 2023, by and between the investor identified on the signature page hereto (the “Investor”) and HeartBeam, Inc., a Delaware corporation (the “Company”). The parties agree as follows: 1. Subscription. Investor agrees to buy and the Company agrees to sell to Investor such number of shares (the “Shares”) of the |
|
| April 10, 2023 |
Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) HeartBeam, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forwar |
|
| March 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEARTBEAM, INC. (Exact Na |
|
| March 16, 2023 |
Exhibit 14.1 HEARTBEAM, INC. Code of Business Conduct and Ethics I. Purpose This Code of Business Conduct and Ethics (the "Code") was adopted to further the commitment of HeartBeam, Inc. (the “Company”) to conducting its business with honesty and integrity. This Code applies to all the employees and officers (all of whom are referred to collectively as “employees”) and directors on the board of di |
|
| March 13, 2023 |
Exhibit 99.1 Breakthrough Cardiac Health Monitoring Always by your side 1 Disclaimers This presentation contains forward - looking statements . All statements other than statements of historical fact contained in this presentation, including statements as to the Company’s future results of operations and financial position, planned products and services, business strategy and plans and objectives |
|
| March 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 9, 2023 |
Exhibit 10.2 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT This First Amendment dated as of March 7, 2023 to that certain Note Purchase Agreement (this “Agreement”) dated as of February 28, 2023, between HeartBeam, Inc., a Delaware corporation (the “Company”), and Maverick Capital Partners, LLC, a Delaware limited liability company (the “Investor”). Capitalized terms not otherwise defined in this Agr |
|
| March 9, 2023 |
Exhibit 10.1 FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT This First Amendment dated as of March 7, 2023 to that certain Securities Purchase Agreement (this “Agreement”) dated as of February 28, 2023, between HeartBeam, Inc., a Delaware corporation (the “Company”), and Maverick Capital Partners, LLC, a Delaware limited liability company (the “Investor”). Capitalized terms not otherwise defined |
|
| March 9, 2023 |
HEARTBEAM, INC. 200,105 Shares of Common Stock Prospectus Supplement Filed Pursuant to Rule 424(b)(2) (to Prospectus dated February 10, 2023) Registration No. |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 8, 2023 |
Exhibit 99.1 HeartBeam Announces Senior Leadership Change Robert Eno Assumes Duties of Chief Business Officer Jon Hunt to Remain Strategic Advisor & Consultant to HeartBeam SANTA CLARA, CA – March 8, 2023 – HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, has |
|
| March 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 3, 2023 |
Note Purchase Agreement dated February 28, 2023 between HeartBeam Inc. and Investors Exhibit 10.2 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (the “Agreement”) is made as of February , 2023, by and between HeartBeam, Inc., a Delaware corporation (the “Company”), and Maverick Capital Partners, LLC, a Delaware limited liability company (the “Investor”). WHEREAS, the Company is seeking interim financing to enable it to further develop, test and market its products; WHEREAS, |
|
| March 3, 2023 |
Securities Purchase Agreement dated February 28, 2023 between HeartBeam Inc. and Investors Exhibit 10.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of February , 2023, by and between HeartBeam, Inc., a Delaware corporation (the “Company”), and Maverick Capital Partners, LLC, a Delaware limited liability company (the “Investor”). WHEREAS, the Company is seeking interim financing to enable it to further develop, test and market its products; WHEREAS |
|
| March 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| February 28, 2023 |
HEARTBEAM, INC. 2118 WALSH AVENUE, SUITE 210 SANTA CLARA, CA 95050 HEARTBEAM, INC. 2118 WALSH AVENUE, SUITE 210 SANTA CLARA, CA 95050 February 28, 2023 VIA EDGAR Ben Richie U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Delaying Amendment for HeartBeam, Inc.’s Registration Statement on Form S-1 (File No. 333-269717) Ladies and Gentlemen: Reference is made to that Registration Statement on Form S |
|
| February 13, 2023 |
US42238H1086 / HeartBeam inc / Ionic Ventures, LLC - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* HeartBeam, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 42238H108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 10, 2023 |
As filed with the Securities and Exchange Commission on February 10, 2023. As filed with the Securities and Exchange Commission on February 10, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incorporation or organizat |
|
| February 10, 2023 |
Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) HeartBeam, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forwar |
|
| February 8, 2023 |
HeartBeam, Inc. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 CORRESP 1 filename1.htm HeartBeam, Inc. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 February 8, 2023 VIA EDGAR U.S. Securities & Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Registration Statement on Form S-3 File No. 333-269520 Ladies and Gentlemen: In accordance with Rule 461 of the Securities Act of 1933, as amended, He |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 2, 2023 |
Calculation of Registration Fee Exhibit 107 CALCULATION OF REGISTRATION FEE TABLE Form S-3 (Form Type) HeartBeam, Inc. |
|
| February 2, 2023 |
Exhibit 4.1 HEARTBEAM, INC. AND , TRUSTEE INDENTURE DATED AS OF , 2023 DEBT SECURITIES HEARTBEAM, INC. RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939 AND INDENTURE, DATED AS OF , 2023 Section of Trust Indenture Act of 1939 Section(s) of Indenture § 310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 § 311(a) 613 (b) 613 (c) Not Applicable § 312( |
|
| February 2, 2023 |
As filed with the Securities Exchange Commission on February 1, 2023 As filed with the Securities Exchange Commission on February 1, 2023 Registration No. |
|
| February 2, 2023 |
Exhibit 1.01 HEARTBEAM, Inc. COMMON STOCK SALES AGREEMENT February 1, 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, NY 10022 Ladies and Gentlemen: HeartBeam, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), as follows: 1. Issuance and Sale of Shares. The Company agrees that, from ti |
|
| January 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2023 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 24, 2023 |
HeartBeam Appoints Robert Eno as President Senior Medical Technology Executive to Enhance Company’s Strategic and Operations Capabilities SANTA CLARA, CA – January 24, 2023 – HeartBeam, Inc. |
|
| January 24, 2023 |
Employment Agreement with Robert Eno, dated January 16, 2023 Exhibit 10.2 HEARTBEAM, INC. Robert P. Eno 15864 Apollo Heights Court Saratoga, CA 95070 By email and DocuSign: Dear Rob: This employment agreement (the “Agreement”) supersedes your consulting agreement of November 13, 2019 last amended November 1, 2022 (the “Old Agreement”), both agreements between you and HeartBeam, Inc. (the “Company”). I am pleased to offer you a position with HeartBeam, Inc. |
|
| November 30, 2022 |
As confidentially filed with the Securities and Exchange Commission on November 30, 2022. As confidentially filed with the Securities and Exchange Commission on November 30, 2022. |
|
| November 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| November 17, 2022 |
Second Amended and Restated Articles of Incorporation dated November 15, 2022. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEARTBEAM, INC. HeartBeam, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?Corporation?), hereby certifies as follows: 1. The name of the Corporation is HeartBeam, Inc. The Corporation?s original Certificate of Incorporation was |
|
| November 10, 2022 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4106 |
|
| October 14, 2022 |
As confidentially filed with the Securities and Exchange Commission on October 14, 2022. As confidentially filed with the Securities and Exchange Commission on October 14, 2022. |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ¨ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy State |
|
| September 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| September 21, 2022 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission |
|
| September 21, 2022 |
Letter from Friedman LLP to Securities and Exchange Commission. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Commissioners: We have read the statements made by HeartBeam, Inc. under Item 4.01 of its Form 8-K dated September 20, 2022. We agree with the statements concerning our firm in such Form 8-K; we are not in a position to agree or disagree with other statements of HeartBeam, Inc. contained therein. Very truly yours, /s/ Fried |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 11, 2022 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEA |
|
| August 8, 2022 |
Supplemental Agreement between HeartBeam, Inc. and LIVMOR, Inc. dated August 2, 2022 Exhibit 10.1 SUPPLEMENTAL AGREEMENT This Supplemental Agreement (this ?Supplemental Agreement?) is made as of August 2, 2022 (the ?Effective Date?), by and between HeartBeam, Inc., a Delaware corporation (?HeartBeam?), and LIVMOR, Inc., a Delaware corporation (?LIVMOR?). WHEREAS, the parties entered into that certain HeartBeam-LIVMOR Partnership Agreement as of January 1, 2022 (collectively with a |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| August 8, 2022 |
Employment Agreement with Ken Persen, dated August 2, 2022 EX-10.2 3 exhibit102-08052022.htm EX-10.2 Exhibit 10.2 August 2, 2022 HEARTBEAM, INC. 2118 Walsh Avenue Suite 210 Santa Clara, CA. 95050 Ken Persen 16 Indian Pipe Dove Canyon, CA. 92679 Dear Ken: I am pleased to offer you a position with HeartBeam, Inc. (the “Company”), as Chief Technical Officer (CTO). If you decide to join us, you will receive an annual salary of $300,000, which will be paid sem |
|
| August 8, 2022 |
Exhibit 99.1 HeartBeam Names Ken Persen as Chief Technology Officer Company Hires Cardiac Industry Veteran to Lead Technology Development SANTA CLARA, Calif. ? August 4, 2022 - HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today the appointment of Ken Persen to the role of Chief |
|
| July 13, 2022 |
2022 Equity Incentive Plan, as amended, and forms of agreement thereunde EX-10.1 3 exhibit101-07122022.htm EX-10.1 Exhibit 10.1 HEARTBEAM, INC. 2022 EQUITY INCENTIVE PLAN (Adopted on April 8, 2022; effective as of the Stockholder Approval Date) 1.Purposes of the Plan; Award Types. (a)Purposes of the Plan. The purposes of this Plan are to attract and retain personnel for positions with the Company Group, to provide additional incentive to Employees, Directors, and Consu |
|
| July 13, 2022 |
Exhibit 107.1 Form S-8 (Form Type) HeartBeam, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1?Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount to be Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.0001 par value per share, reserved for i |
|
| July 13, 2022 |
As filed with the Securities and Exchange Commission on July 12, 2022 As filed with the Securities and Exchange Commission on July 12, 2022 Registration No. |
|
| June 16, 2022 |
HEARTBEAM, INC. 2022 EQUITY INCENTIVE PLAN (Adopted on April 8, 2022; effective as of the Stockholder Approval Date) 1.Purposes of the Plan; Award Types. (a)Purposes of the Plan. The purposes of this Plan are to attract and retain personnel for positions with the Company Group, to provide additional incentive to Employees, Directors, and Consultants (collectively, ?Service Providers?), and to prom |
|
| June 16, 2022 |
Submission of Matters to a Vote of Security Holders 8-K 1 form8-kx06162022.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of i |
|
| May 12, 2022 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HE |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41060 HEARTBEAM, INC. (Exact Na |
|
| March 10, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission File |
|
| March 10, 2022 |
HeartBeam Partners with Triple Ring Technologies to Co-Develop Telehealth Solution Device 3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 SANTA CLARA, CA ? March 10, 2022 - HeartBeam, Inc. |
|
| March 10, 2022 |
Form of Professional Services Agreement between Triple Ring and HeartBeam, Inc. dated March 7, 2022 EX-10.1 2 exhibit101-03102022.htm EX-10.1 Triple Ring Technologies, Inc. 39655 Eureka Drive Newark CA 94560 (510) 592-3000 fax (510) 592-3001 www.tripleringtech.com PROFESSIONAL SERVICES AGREEMENT This Agreement (the “Agreement”) is entered into as of the 7th day of March 2022, between Triple Ring Technologies, Inc. (“the Company”) and HeartBeam, Inc. (“the Client”). WHEREAS, the Company is willin |
|
| February 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| February 22, 2022 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February18, 2022, between HeartBeam, Inc. |
|
| February 3, 2022 |
BEAT / Heatbeam / Ionic Ventures, LLC - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* HeartBeam, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 42238H108 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2022 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 2, 2022 |
HeartBeam Partners with LIVMOR for Cloud Based Remote Monitoring Portal LIVMOR to Develop HeartBeam Branded Version of the FDA Registered LIVMOR Halo+ Portal SANTA CLARA, CA ? February 2, 2022 - HeartBeam, Inc. |
|
| February 2, 2022 |
Partnership Agreement between HeartBeam, Inc. and LIVMOR, Inc. dated January 31, 2022 Confidential Execution Version CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. |
|
| December 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2021 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 001-41060 47-4881450 (State or other jurisdiction of incorporation) (Commission F |
|
| December 27, 2021 |
EX-10.1 2 exhibit101.htm EX-10.1 HEARTBEAM, INC. December 20, 2021 Alan Baumel 3501 N. 25th St. Phoenix, AZ 85016 Dear Alan: This agreement (the “Agreement”) supersedes your agreement of October 6, 2021 (the “Old Agreement”), both agreements between you and HeartBeam, Inc. (the “Company”). The Old Agreement reflected your responsibilities of primarily leading the effort to incorporate the Company’ |
|
| December 27, 2021 |
EX-99.1 3 exhibit991.htm EX-99.1 HeartBeam Appoints Alan Baumel as Chief Operating Officer Commercial Medical Device Veteran to Lead Rollout of HeartBeam Platform Technology SANTA CLARA, CA – December 22, 2021 - HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, has app |
|
| December 16, 2021 |
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4106 |
|
| December 1, 2021 |
2015 Equity Incentive Plan, as amended, and forms of agreement thereunder. Exhibit 10.1 HEARTBEAM, INC. 2015 EQUITY INCENTIVE PLAN 1. Purposes of the Plan. The purposes of this Plan are: ? to attract and retain the best available personnel for positions of substantial responsibility, ? to provide additional incentive to Employees, Directors and Consultants, and ? to promote the success of the Company?s business. The Plan permits the grant of Incentive Stock Options, Nons |
|
| December 1, 2021 |
Specimen Common Stock certificate. Exhibit 4.1 NUMBER: C- SHARES: SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 541714 HEARTBEAM, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF THE PAR VALUE OF $0.0001 EACH OF HEARTBEAM, INC. (THE ?COMPANY?) transferable on the books of the Company in person or by duly authorized attorney |
|
| December 1, 2021 |
As filed with the Securities and Exchange Commission on November 30, 2021 As filed with the Securities and Exchange Commission on November 30, 2021 Registration No. |
|
| November 18, 2021 |
Filed Pursuant to Rule 424(b)(1) Registration No. 333-259358 424B1 1 f424b11121heartbeam.htm PROSPECTUS Filed Pursuant to Rule 424(b)(1) Registration No. 333-259358 PROSPECTUS HeartBeam, Inc. 2,750,000 Units This is an initial public offering of units of securities (the “Units) of HeartBeam, Inc (the “Company” or “HeartBeam”). Each Unit consists of (a) one share of our Common Stock (“Common Stock”) and (b) Warrant (the “Warrants”) to purchase one share of o |
|
| November 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2021 HEARTBEAM, INC. |
|
| November 17, 2021 |
HeartBeam Announces Pricing of $16.5 Million Initial Public Offering Exhibit 99.1 HeartBeam Announces Pricing of $16.5 Million Initial Public Offering SANTA CLARA, Calif.-(BUSINESS WIRE)-HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the pricing of its initial public offering of 2,750,000 units, each consisting of (i) |
|
| November 17, 2021 |
Underwriting Agreement, by and between HeartBeam, Inc. and The Benchmark Company EX-1.1 2 ea150893ex1-1heartbeaminc.htm UNDERWRITING AGREEMENT, BY AND BETWEEN HEARTBEAM, INC. AND THE BENCHMARK COMPANY Exhibit 1.1 UNDERWRITING AGREEMENT November 10, 2021 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representative of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, HeartBeam, Inc., a Delaware co |
|
| November 17, 2021 |
HeartBeam Announces Closing of Initial Public Offering EX-99.2 5 ea150893ex99-2heartbeaminc.htm PRESS RELEASE DATED NOVEMBER 17, 2021 Exhibit 99.2 HeartBeam Announces Closing of Initial Public Offering November 17, 2021 08:31 AM Eastern Standard Time SANTA CLARA, Calif.-(BUSINESS WIRE)-HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascu |
|
| November 17, 2021 |
Warrant Agency Agreement by and between HeartBeam, Inc. and VStock Transfer, LLC including Warrants Exhibit 4.14 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this ?Warrant Agreement?) dated as of November 15, 2021 (the ?Issuance Date?) between HeartBeam, Inc., a Delaware corporation (the ?Company?), and VStock Transfer, LLC (the ?Warrant Agent?). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (?Underwriting Agreement?), dated November 10, 2021, by and between the Compa |
|
| November 16, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* HeartBeam, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 42238H108 (CUSIP Number) November 11, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| November 12, 2021 |
Filed Pursuant to Rule 424(b)(1) Registration No. 333-259358 Filed Pursuant to Rule 424(b)(1) Registration No. 333-259358 PROSPECTUS HeartBeam, Inc. 2,750,000 Units This is an initial public offering of units of securities (the ?Units) of HeartBeam, Inc (the ?Company? or ?HeartBeam?). Each Unit consists of (a) one share of our Common Stock (?Common Stock?) and (b) Warrant (the ?Warrants?) to purchase one share of our Common Stock at an exercise price equal |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 HEARTBEAM, INC. (Exact name of registrant as specified in its charter) Delaware 47-4881450 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2118 |
|
| November 9, 2021 |
As filed with the Securities and Exchange Commission on November 9, 2021. As filed with the Securities and Exchange Commission on November 9, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 6 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incor |
|
| November 8, 2021 |
Form of Representative’s Warrant Exhibit 4.13 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [?], 2021, WHICH IS THE |
|
| November 8, 2021 |
Power of Attorney (included in the signature page of this Registration Statement) As filed with the Securities and Exchange Commission on November 8, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 5 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incor |
|
| November 8, 2021 |
HEARTBEAM, INC. 2118 WALSH AVENUE, SUITE 210 SANTA CLARA, CA 95050 HEARTBEAM, INC. 2118 WALSH AVENUE, SUITE 210 SANTA CLARA, CA 95050 November 8, 2020 VIA EDGAR Tom Kluck U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Registration Statement on Form S-1 (File No. 333-259358) Ladies and Gentlemen: In accordance with Rule 461 of the Securities Act of 1933, as amended, HeartBeam, Inc. hereby respectfully requests |
|
| November 8, 2021 |
November 8, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam Inc. Registration Statement on Form S-1, as amended (File No. 333-259358) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the ?Act?), The Benchmark Compan |
|
| November 8, 2021 |
Form of Underwriting Agreement EX-1.1 2 ea150126ex1-1heartbeaminc.htm FORM OF UNDERWRITING AGREEMENT Exhibit 1.1 UNDERWRITING AGREEMENT [●], 2021 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representative of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, HeartBeam, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement ( |
|
| November 8, 2021 |
Form of Warrant Agency Agreement EX-4.14 4 ea150126ex4-14heartbeaminc.htm FORM OF WARRANT AGENCY AGREEMENT Exhibit 4.14 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of November 15, 2021 (the “Issuance Date”) between HeartBeam, Inc., a Delaware corporation (the “Company”), and VStock Transfer, a [ ] (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement ( |
|
| November 2, 2021 |
As filed with the Securities and Exchange Commission on November 2, 2021. As filed with the Securities and Exchange Commission on November 2, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incor |
|
| November 1, 2021 |
FWP 1 ea149712-fwpheartbeaminc.htm FREE WRITING PROSPECTUS Medical Grade Heart Attack Detection Always with the patient Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration no. 333 - 259358 Relating to Preliminary Prospectus dated October 12, 2021 This presentation includes forward - looking statements that involve substantial risks and uncertainties . All statements, other than |
|
| November 1, 2021 |
As filed with the Securities and Exchange Commission on November 1, 2021. As filed with the Securities and Exchange Commission on November 1, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 3 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incor |
|
| October 19, 2021 |
October 19, 2021 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N. |
|
| October 12, 2021 |
HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 CORRESP 1 filename1.htm HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 October 12, 2021 Mary Mast U.S. Securities & Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed October 4, 2021 File No. 333-259358 Dear Ms. Mast: By letter dated October 7, 2021, the staff (the “Staff,” “you” or “your |
|
| October 12, 2021 |
As filed with the Securities and Exchange Commission on October 12, 2021. As filed with the Securities and Exchange Commission on October 12, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incor |
|
| October 12, 2021 |
Standard Business Terms and Conditions Agreement with Ximedica, dated August 20, 2021 Exhibit 10.4 Ximedica Standard Business Terms and Conditions August 20, 2021 These Standard Business Terms and Conditions (the “Terms”) are entered in by and between HeartBeam, Inc., a California Corporation with principal offices located at 2118 Walsh Road, Santa Clara (“CLIENT”) and Ximedica, LLC, a Rhode Island limited liability company (“XIMEDICA”) (each a “Party” and together the “Parties”) i |
|
| October 12, 2021 |
Amendment No. 7 dated as of October 7, 2021 to the 2015 Convertible Promissory Note EX-4.12 2 fs12021a2ex4-12heartbeam.htm AMENDMENT NO. 7 DATED AS OF OCTOBER 7, 2021 TO THE 2015 CONVERTIBLE PROMISSORY NOTE Exhibit 4.12 HEARTBEAM, INC. AMENDMENT NO. 7 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 7 to 2015 Note Subscription Agreements (this “Amendment”) is made and entered into as of October 7, 2021 (the “Effective Date”) by and among HeartBeam, Inc., a Delaware corpora |
|
| October 4, 2021 |
As filed with the Securities and Exchange Commission on October 4, 2021. As filed with the Securities and Exchange Commission on October 4, 2021. Registration Statement No. 333-259358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incorp |
|
| October 4, 2021 |
Employment Agreement with Richard Brounstein Exhibit 10.2 HEARTBEAM, INC. September 10, 2021 Richard Brounstein [address] Dear Rick: This letter memorializes certain terms of your ongoing employment with HeartBeam, Inc. (the ?Company?). You will continue in your position with the Company as its Chief Financial Officer. You will receive an annual salary of $187,000, commencing on September 15, 2021, which will be paid semi-monthly in accordan |
|
| October 4, 2021 |
Amendment to Articles of Incorporation filed with the State of Delaware on September 27, 2021. Exhibit 3.3 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEARTBEAM, INC. HeartBeam, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?Corporation?), hereby certifies as follows: 1. The name of the Corporation is HeartBeam, Inc. The Corporation?s original Certificate of Incorporation was |
|
| October 4, 2021 |
Employment Agreement with Branislav Vajdic EX-10.1 3 fs12021a1ex10-1heartbeam.htm EMPLOYMENT AGREEMENT WITH BRANISLAV VAJDIC Exhibit 10.1 HEARTBEAM, INC. September 10, 2021 Branislav Vajdic [Address] Dear Branislav: This letter memorializes certain terms of your ongoing employment with HeartBeam, Inc. (the “Company”). You will continue in your position with the Company as its Chief Executive Officer and a member of the Company’s Board of D |
|
| October 4, 2021 |
Employment Agreement with Jon Hunt EX-10.3 5 fs12021a1ex10-3heartbeam.htm EMPLOYMENT AGREEMENT WITH JON HUNT Exhibit 10.3 HEARTBEAM, INC. September 17, 2021 Jon Hunt [Address] Dear Jon: I am pleased to offer you a position with HeartBeam, Inc. (the “Company”), as Executive Vice President and Chief Business Officer. If you decide to join us, you will receive an annual salary of $275,000, commencing on September 15, 2021, which will |
|
| October 4, 2021 |
HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 October 4, 2021 Mary Mast U.S. Securities & Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Registration Statement on Form S-1 Filed September 7, 2021 File No. 333-259358 Dear Ms. Mast: By letter dated September 14, 2021, the staff (the ?Staff,? ?you? or ?your?) of the U.S. Securities & Exchange Co |
|
| September 7, 2021 |
Amendment No. 5 dated as of May 13, 2020 to the 2015 Convertible Promissory Note Exhibit 4.10 HEARTBEAM, INC. AMENDMENT NO. 5 TO CONVERTIBLE PROMISSORY NOTES This Amendment No. 5 to Convertible Promissory Notes, effective as of May 13, 2020 (the ?Amendment?), is entered into by and among HeartBeam, Inc. (the ?Company?) and certain holders of convertible promissory notes issued by the Company (the ?Investors?). Capitalized terms not defined herein shall have the terms ascribed |
|
| September 7, 2021 |
Amendment No. 1 dated as of May 3, 2016 to the 2015 Note Subscription Agreement EX-4.3 6 fs12021ex4-3heartbeam.htm AMENDMENT NO. 1 DATED AS OF MAY 3, 2016 TO THE 2015 NOTE SUBSCRIPTION AGREEMENT Exhibit 4.3 HEARTBEAM, INC. AMENDMENT NO. 1 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 1 to 2015 Note Subscription Agreements (this “Amendment”) is made and entered into as of May 3, 2016 (the “Effective Date”) by and among HeartBeam, Inc., a Delaware corporation (the “Co |
|
| September 7, 2021 |
EX-3.2 3 fs12021ex3-2heartbeam.htm BYLAWS Exhibit 3.2 BYLAWS OF HEARTBEAM, INC. Adopted on August 11, 2015 TABLE OF CONTENTS Page ARTICLE I — MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders’ Meetings 1 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 2 1.9 Stockholder Action by Written Consent |
|
| September 7, 2021 |
Amendment No. 5 dated as of May 13, 2020 to the 2015 Note Subscription Agreement Exhibit 4.9 HEARTBEAM, INC. AMENDMENT NO. 5 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 5 to 2015 Note Subscription Agreements (this ?Amendment?) is made and entered into effective as of May 13, 2020 (the ?Effective Date?) by and among HeartBeam, Inc., a Delaware corporation (the ?Company?) and certain of the persons and/or entities (each, an ?Investor? and together, the ?Investors?) s |
|
| September 7, 2021 |
Amendment No. 2 dated as of March 2, 2017 to the 2015 Note Subscription Agreement EX-4.4 7 fs12021ex4-4heartbeam.htm AMENDMENT NO. 2 DATED AS OF MARCH 2, 2017 TO THE 2015 NOTE SUBSCRIPTION AGREEMENT Exhibit 4.4 HEARTBEAM, INC. AMENDMENT NO. 2 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 2 to 2015 Note Subscription Agreements (this “Amendment”) is made and entered into as of March 2, 2017, (the “Effective Date”) by and among HeartBeam, Inc., a Delaware corporation (th |
|
| September 7, 2021 |
HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 September 7, 2021 David Burton U.S. Securities & Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Amendment No. 2 to Draft Registration Statement on Form S-1 Submitted July 9, 2021 CIK No. 0001779372 Dear Mr. Burton: By letter dated July 21, 2021, the staff (the ?Staff,? ?you? or ?your?) of the U.S. |
|
| September 7, 2021 |
Form of 2015 Convertible Promissory Note EX-4.2 5 fs12021ex4-2heartbeam.htm FORM OF 2015 CONVERTIBLE PROMISSORY NOTE Exhibit 4.2 2015 NOTE SUBSCRIPTION AGREEMENT This 2015 Note Subscription Agreement, dated as of , 2021 (this “Agreement”), is entered into by and between HeartBeam, Inc., a Delaware corporation (the “Company”), and the person or entity listed on the signature page hereto (the “Investor”). RECITALS A. On the terms and subje |
|
| September 7, 2021 |
Amendment No. 4 dated as of September 6, 2018 to the 2015 Convertible Promissory Note EX-4.8 11 fs12021ex4-8heartbeam.htm AMENDMENT NO. 4 DATED AS OF SEPTEMBER 6, 2018 TO THE 2015 CONVERTIBLE PROMISSORY NOTE Exhibit 4.8 HEARTBEAM, INC. AMENDMENT NO. 4 TO CONVERTIBLE PROMISSORY NOTES This Amendment No. 4 to Convertible Promissory Notes, dated as of September 6, 2018 (the “Amendment”), is entered into by and among HeartBeam, Inc. (the “Company”) and certain holders of convertible pro |
|
| September 7, 2021 |
Articles of Incorporation filed with the State of Delaware on June 11, 2015. Exhibit 3.1 Delaware PAGE 1 The first State I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF ?HEARTBEAM, INC.?, FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JUNE, A.D. 2015, AT 8:48 O?CLOCK P.M. A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CASTLE COUNTY RECORDER OF D |
|
| September 7, 2021 |
Amendment No. 6 dated as of March 22, 2021 to the 2015 Convertible Promissory Note EX-4.11 14 fs12021ex4-11heartbeam.htm AMENDMENT NO. 6 DATED AS OF MARCH 22, 2021 TO THE 2015 CONVERTIBLE PROMISSORY NOTE Exhibit 4.11 AMENDMENT NO. 6 TO CONVERTIBLE PROMISSORY NOTES THIS AMENDMENT NO. 6 TO CONVERTIBLE PROMISSORY NOTES (this “Amendment”) is made and entered into effective as of date a majority of the note holders have signed (“Effective Date”), by and between HEARTBEAM, INC., a Del |
|
| September 7, 2021 |
EX-4.6 9 fs12021ex4-6heartbeam.htm AMENDMENT NO. 3 DATED AS OF JANUARY 18, 2018 TO THE NOTE SUBSCRIPTION AGREEMENT AND THE CONVERTIBLE PROMISSORY NOTE Exhibit 4.6 HEARTBEAM, INC. Action By Unanimous Written Consent of the Board of Directors Pursuant to Section 141(f) of the Delaware General Corporation Law and the bylaws of HeartBeam, Inc., a Delaware corporation (the “Company”), the undersigned, |
|
| September 7, 2021 |
Amendment No. 2 dated as of March 2, 2017 to the 2015 Convertible Promissory Note Exhibit 4.5 HEARTBEAM, INC. AMENDMENT TO CONVERTIBLE PROMISSORY NOTES This Amendment to Convertible Promissory Notes, dated as of March 2, 2017, (the ?Amendment?), is entered into by and among HeartBeam, Inc. (the ?Company?) and certain holders of convertible promissory notes issued by the Company (the ?Investors?). Capitalized terms not defined herein shall have the terms ascribed to them in the |
|
| September 7, 2021 |
As filed with the Securities and Exchange Commission on September 7, 2021. Registration Statement No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEARTBEAM, INC. (Exact name of Registrant as specified in its charter) Delaware 541714 47-4881450 (State or other jurisdiction of incorporation or organization) |
|
| September 7, 2021 |
Form of 2015 Note Subscription Agreement EX-4.1 4 fs12021ex4-1heartbeam.htm FORM OF 2015 NOTE SUBSCRIPTION AGREEMENT Exhibit 4.1 2015 NOTE SUBSCRIPTION AGREEMENT This 2015 Note Subscription Agreement, dated as of , 2021 (this “Agreement”), is entered into by and between HeartBeam, Inc., a Delaware corporation (the “Company”), and the person or entity listed on the signature page hereto (the “Investor”). RECITALS A. On the terms and subje |
|
| September 7, 2021 |
Amendment No. 4 dated as of September 6, 2018 to the 2015 Note Subscription Agreement Exhibit 4.7 HEARTBEAM, INC. AMENDMENT NO. 4 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 4 to 2015 Note Subscription Agreements (this ?Amendment?) is made and entered into as of September 6, 2018 (the ?Effective Date?) by and among HeartBeam, Inc., a Delaware corporation (the ?Company?) and certain of the persons and/or entities (each, an ?Investor? and together, the ?Investors?) set fo |
|
| July 9, 2021 |
HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 HEARTBEAM, INC. 2118 Walsh Avenue, Suite 210 Santa Clara, CA 95050 July 9th, 2021 David Burton U.S. Securities & Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HeartBeam, Inc. Draft Registration Statement on Form S-1 Submitted May 14, 2021 CIK No. 0001779372 Dear Mr. Burton: By letter dated June 11, 2021, the staff (the ?Staff,? ?you? or ?your?) of the U.S. Securities & Exchange |
|
| July 9, 2021 |
As confidentially submitted with the Securities and Exchange Commission on July 9, 2021. |
|
| May 14, 2021 |
CERTIFICATE OF INCORPORATION OF HEARTBEAM, INC. ARTICLE I EX-3.1 2 filename2.htm Exhibit 3.1 Delaware PAGE 1 The first State I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF “HEARTBEAM, INC.”, FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JUNE, A.D. 2015, AT 8:48 O’CLOCK P.M. A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CAST |
|
| May 14, 2021 |
2015 NOTE SUBSCRIPTION AGREEMENT EX-4.2 5 filename5.htm Exhibit 4.2 2015 NOTE SUBSCRIPTION AGREEMENT This 2015 Note Subscription Agreement, dated as of , 2021 (this “Agreement”), is entered into by and between HeartBeam, Inc., a Delaware corporation (the “Company”), and the person or entity listed on the signature page hereto (the “Investor”). RECITALS A. On the terms and subject to the conditions set forth herein, the Investor i |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 1 TO 2015 NOTE SUBSCRIPTION AGREEMENTS EX-4.3 6 filename6.htm Exhibit 4.3 HEARTBEAM, INC. AMENDMENT NO. 1 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 1 to 2015 Note Subscription Agreements (this “Amendment”) is made and entered into as of May 3, 2016 (the “Effective Date”) by and among HeartBeam, Inc., a Delaware corporation (the “Company”) and certain of the persons and/or entities (each, an “Investor” and together, the “I |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 4 TO 2015 NOTE SUBSCRIPTION AGREEMENTS Exhibit 4.7 HEARTBEAM, INC. AMENDMENT NO. 4 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 4 to 2015 Note Subscription Agreements (this ?Amendment?) is made and entered into as of September 6, 2018 (the ?Effective Date?) by and among HeartBeam, Inc., a Delaware corporation (the ?Company?) and certain of the persons and/or entities (each, an ?Investor? and together, the ?Investors?) set fo |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 4 TO CONVERTIBLE PROMISSORY NOTES EX-4.8 11 filename11.htm Exhibit 4.8 HEARTBEAM, INC. AMENDMENT NO. 4 TO CONVERTIBLE PROMISSORY NOTES This Amendment No. 4 to Convertible Promissory Notes, dated as of September 6, 2018 (the “Amendment”), is entered into by and among HeartBeam, Inc. (the “Company”) and certain holders of convertible promissory notes issued by the Company (the “Investors”). Capitalized terms not defined herein shall |
|
| May 14, 2021 |
HEARTBEAM, INC. Action By Unanimous Written Consent of the Board of Directors Exhibit 4.6 HEARTBEAM, INC. Action By Unanimous Written Consent of the Board of Directors Pursuant to Section 141(f) of the Delaware General Corporation Law and the bylaws of HeartBeam, Inc., a Delaware corporation (the ?Company?), the undersigned, constituting all the members of the board of directors of the Company (the ?Board?), resolve as follows: 1. Amendment of 2015 Notes and Note Subscripti |
|
| May 14, 2021 |
AMENDMENT NO. 6 TO CONVERTIBLE PROMISSORY NOTES EX-4.11 14 filename14.htm Exhibit 4.11 AMENDMENT NO. 6 TO CONVERTIBLE PROMISSORY NOTES THIS AMENDMENT NO. 6 TO CONVERTIBLE PROMISSORY NOTES (this “Amendment”) is made and entered into effective as of date a majority of the note holders have signed (“Effective Date”), by and between HEARTBEAM, INC., a Delaware corporation (the “Company”) and certain holders of convertible promissory notes issued by |
|
| May 14, 2021 |
BYLAWS OF HEARTBEAM, INC. Adopted on August 11, 2015 TABLE OF CONTENTS EX-3.2 3 filename3.htm Exhibit 3.2 BYLAWS OF HEARTBEAM, INC. Adopted on August 11, 2015 TABLE OF CONTENTS Page ARTICLE I — MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders’ Meetings 1 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 2 1.9 Stockholder Action by Written Consent Without a Meeting |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT TO CONVERTIBLE PROMISSORY NOTES EX-4.5 8 filename8.htm Exhibit 4.5 HEARTBEAM, INC. AMENDMENT TO CONVERTIBLE PROMISSORY NOTES This Amendment to Convertible Promissory Notes, dated as of March 2, 2017, (the “Amendment”), is entered into by and among HeartBeam, Inc. (the “Company”) and certain holders of convertible promissory notes issued by the Company (the “Investors”). Capitalized terms not defined herein shall have the terms a |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 5 TO CONVERTIBLE PROMISSORY NOTES Exhibit 4.10 HEARTBEAM, INC. AMENDMENT NO. 5 TO CONVERTIBLE PROMISSORY NOTES This Amendment No. 5 to Convertible Promissory Notes, effective as of May 13, 2020 (the ?Amendment?), is entered into by and among HeartBeam, Inc. (the ?Company?) and certain holders of convertible promissory notes issued by the Company (the ?Investors?). Capitalized terms not defined herein shall have the terms ascribed |
|
| May 14, 2021 |
2015 NOTE SUBSCRIPTION AGREEMENT Exhibit 4.1 2015 NOTE SUBSCRIPTION AGREEMENT This 2015 Note Subscription Agreement, dated as of , 2021 (this ?Agreement?), is entered into by and between HeartBeam, Inc., a Delaware corporation (the ?Company?), and the person or entity listed on the signature page hereto (the ?Investor?). RECITALS A. On the terms and subject to the conditions set forth herein, the Investor is willing to purchase f |
|
| May 14, 2021 |
As confidentially submitted with the Securities and Exchange Commission on May 14, 2021. |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 2 TO 2015 NOTE SUBSCRIPTION AGREEMENTS EX-4.4 7 filename7.htm Exhibit 4.4 HEARTBEAM, INC. AMENDMENT NO. 2 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 2 to 2015 Note Subscription Agreements (this “Amendment”) is made and entered into as of March 2, 2017, (the “Effective Date”) by and among HeartBeam, Inc., a Delaware corporation (the “Company”) and certain of the persons and/or entities (each, an “Investor” and together, the |
|
| May 14, 2021 |
HEARTBEAM, INC. AMENDMENT NO. 5 TO 2015 NOTE SUBSCRIPTION AGREEMENTS Exhibit 4.9 HEARTBEAM, INC. AMENDMENT NO. 5 TO 2015 NOTE SUBSCRIPTION AGREEMENTS This Amendment No. 5 to 2015 Note Subscription Agreements (this ?Amendment?) is made and entered into effective as of May 13, 2020 (the ?Effective Date?) by and among HeartBeam, Inc., a Delaware corporation (the ?Company?) and certain of the persons and/or entities (each, an ?Investor? and together, the ?Investors?) s |
